Serotonin transporter promoter polymorphism in African Americans: Allele frequencies and implications for treatment

American Journal of PharmacoGenomics

Volumn 3, Issue 2, 2003, Pages 145-147

  Lotrich, Francis E ^a   Pollock, Bruce G ^a   Ferrell, Robert E ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR DEPRESSION; NEGRO; NORMAL HUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PROMOTER REGION; TRINIDAD AND TOBAGO; UNITED STATES;

AFRICAN AMERICANS; CARRIER PROTEINS; CHI-SQUARE DISTRIBUTION; GENE FREQUENCY; GENOTYPE; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PENNSYLVANIA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SOUTH CAROLINA; TRINIDAD AND TOBAGO;

EID: 0038014055     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200303020-00007     Document Type: Article

References (17)

1. Olfson M, Marcus S, Druss B, et al. National trends in the outpatient treatment of depression. JAMA 2002; 287 (2): 203-9
2. Sclar DA, Robison LM, Skaer TL, et al. Ethnicity and the prescribing of antidepressant pharmacotherapy: 1992-1995. Harv Rev Psychiatry 1999; 7: 29-36
3. Melfi CA, Croghan TW, Hanna MP, et al. Racial variation in antidepressant treatment in a Medicaid population. J Clin Psychiatry 2000; 61: 16-21
4. Heils A, Mossner R, Lesch KP. The human serotonin transporter gene polymorphism: basic research and clinical implication, J Neural Transm 1997; 104 (10): 1005-14
5. Lotrich FE, Pollock BG, Ferrell RE. Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors. Am J Pharmacogenomics 2001; 1 (3): 153-64
6. Zanardi R, Benedetti F, Di Bella D, et al. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol 2000; 20 (1): 105-6
7. Zanardi R, Benedetti F, Serretti A, et al. Genetic influence on response to serotonergic antidepressants [abstract]. Am J Med Genet 2000 Aug; 96 (4): 538
8. Pollock BG, Ferrell RE, Mulsant BH, et al. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 2000; 23 (5): 587-90
9. Arias G, Gasto C, Catalan R, et al. Variation in the serotonin transporter gene and clinical response to citalopram in major depression [abstract]. Am J Med Genet 2000 Aug; 96 (4): 536
10. Rausch JL, Johnson ME, Fei Y-J, et al. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol Psychiatry 2002; 51: 723-32
11. Gelernter J, Cubells JF, Kidd JR, et al. Population studies of polymorphisms of the serotonin transporter protein gene. Am J Med Genet 1999; 88: 61-6
12. Gelernter J, Kranzler H, Coccaro EF, et al. Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. Am J Psychiatry 1998; 155: 1332-8
13. Flory JD, Manuck SB, Ferrell RE, et al. Neuroticism is not associated with the serotonin transporter (5-HTTPR) polymorphism. Mol Psychiatry 1999; 4: 93-6
14. Yu YW-Y, Tsai S-J, Chen T-J, et al. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 2002; 7: 1115-9
15. Kim DK, Lim S-W, Lee S, et al. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 2000; 11 (1): 215-9
16. Cubeddu LX, Aranda J, Singh B, et al. A comparison of verapamil and propranolol for the initial treatment of hypertension: racial differences in response. JAMA 1986; 256: 2214-21
17. Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics 2002; 3 (2): 229-43.